Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Emily R, Locke"'
Autor:
Margie E. Snyder, Khoa A. Nguyen, Himalaya Patel, Steven L. Sanchez, Morgan Traylor, Michelle J. Robinson, Teresa M. Damush, Peter Taber, Amanda S. Mixon, Vincent S. Fan, April Savoy, Rachel A. Dismore, Brian W. Porter, Kenneth S. Boockvar, David A. Haggstrom, Emily R. Locke, Bryan S. Gibson, Susan H. Byerly, Michael Weiner, Alissa L. Russ-Jara
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Medication reconciliation is essential for optimizing medication use. In part to promote effective medication reconciliation, the Department of Veterans Affairs (VA) invested substantial resources in health information exchange (H
Externí odkaz:
https://doaj.org/article/b20c947b7ee84e719f1ce3d237ee8c27
Autor:
Colin Bartz-Overman, Anita M. Albanese, Vincent Fan, Emily R. Locke, Toral Parikh, Stephen Thielke
Publikováno v:
COPD, Vol 19, Iss 1, Pp 282-289 (2022)
Previous research has identified unexpectedly strong associations between dyspnea and pain, but the reasons remain unclear. Ascertaining the underlying biological and psychological mechanisms might enhance the understanding of the experience of both
Externí odkaz:
https://doaj.org/article/336902a99809424dbdd7e0c841838acb
Autor:
Emily R. Locke, Jessica P. Young, Catherine Battaglia, Tracy L. Simpson, Ranak Trivedi, Carol Simons, John C. Fortney, Paul Hebert, Erik R. Swenson, Jeffrey Edelman, Vincent S. Fan
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 32, Iss 1, Pp 1-8 (2022)
Abstract Patients who receive earlier treatment for acute exacerbations of chronic obstructive pulmonary disease (COPD) have a better prognosis, including earlier symptom resolution and reduced risk of future emergency-department visits (ED) or hospi
Externí odkaz:
https://doaj.org/article/374fe7a0f19c474eae4942d8efa66a9c
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101326- (2022)
Summary: Background: mRNA COVID-19 vaccines manufactured by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) have been shown to be efficacious but have not been compared in head-to-head clinical trials. Methods: We designed this observational study
Externí odkaz:
https://doaj.org/article/bd513bf421e745afaa1c04f070cbdb21
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0259696 (2021)
BackgroundWe aimed to determine factors independently associated with early COVID-19 vaccination and adherence to two-dose regimens.MethodsAmong persons receiving care in the Veterans Affairs (VA) healthcare system (n = 5,766,638), we identified thos
Externí odkaz:
https://doaj.org/article/2e8e0756f0c3489ca0cde37f300bef93
Autor:
Emily R. Locke, Jessica P. Young, Catherine Battaglia, Tracy L. Simpson, Ranak Trivedi, Carol Simons, John C. Fortney, Paul Hebert, Erik R. Swenson, Jeffrey Edelman, Vincent S. Fan
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 32, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/58840fa5da9d4d6980ca95eee91a8eec
Autor:
George N, Ioannou, Amy S B, Bohnert, Ann M, O'Hare, Edward J, Boyko, Matthew L, Maciejewski, Valerie A, Smith, C Barrett, Bowling, Elizabeth, Viglianti, Theodore J, Iwashyna, Denise M, Hynes, Kristin, Berry, Emily R, Locke
Publikováno v:
Annals of Internal Medicine. 175:1693-1706
The effectiveness of a third mRNA COVID-19 vaccine dose (booster dose) against the Omicron (B.1.1.529) variant is uncertain, especially in older, high-risk populations.To determine mRNA booster vaccine effectiveness (VE) against SARS-CoV-2 infection,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99dda3cd10c7cc408b4f31ecc86cdbda
https://doi.org/10.7326/m22-1856
https://doi.org/10.7326/m22-1856
Autor:
George N. Ioannou, Emily R. Locke, Ann M. O’Hare, Amy S.B. Bohnert, Edward J. Boyko, Denise M. Hynes, Kristin Berry
Publikováno v:
Annals of Internal Medicine
In a target trial emulation study that included nearly 6 million predominately male patients receiving care in the U.S. Department of Veterans Affairs health care system, those receiving messenger RNA vaccines against SARS-CoV-2 were matched 1:1 to u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb6972504706095f732717984f961c9
https://doi.org/10.7326/m21-3256
https://doi.org/10.7326/m21-3256
Autor:
Ann M, O'Hare, Elizabeth K, Vig, Theodore J, Iwashyna, Alexandra, Fox, Janelle S, Taylor, Elizabeth M, Viglianti, Catherine R, Butler, Kelly C, Vranas, Mark, Helfand, Anaïs, Tuepker, Shannon M, Nugent, Kara A, Winchell, Ryan J, Laundry, C Barrett, Bowling, Denise M, Hynes, Matthew L, Maciejewski, Amy S B, Bohnert, Emily R, Locke, Edward J, Boyko, George N, Ioannou
Publikováno v:
JAMA network open. 5(11)
There is increasing recognition of the long-term health effects of SARS-CoV-2 infection (sometimes called long COVID). However, little is yet known about the clinical diagnosis and management of long COVID within health systems.To describe dominant t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8182f692d54a76802442e0c4d16e645d
https://pubmed.ncbi.nlm.nih.gov/36326761
https://pubmed.ncbi.nlm.nih.gov/36326761
Autor:
Emily R, Locke, Jessica P, Young, Catherine, Battaglia, Tracy L, Simpson, Ranak, Trivedi, Carol, Simons, John C, Fortney, Paul, Hebert, Erik R, Swenson, Jeffrey, Edelman, Vincent S, Fan
Publikováno v:
NPJ primary care respiratory medicine. 32(1)
Patients who receive earlier treatment for acute exacerbations of chronic obstructive pulmonary disease (COPD) have a better prognosis, including earlier symptom resolution and reduced risk of future emergency-department visits (ED) or hospitalizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c973638ef130e51c6a840fd8a975347e
https://pubmed.ncbi.nlm.nih.gov/35462558
https://pubmed.ncbi.nlm.nih.gov/35462558